A novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises (SMEs), their suppliers, service providers and research institutes at the interface of nanomaterials and nanomedicine. The Swiss partners in the consortium were funded by Innosuisse.
Guidelines: Safe-by-design for medicinal polymeric nanocarriers
Related articles
CLINAM
25.-28.10.20, 12th European and Global CLINAM‐Summit, Basel, Programme
Medical Device Regulation...
Join us on December 14, 2020 for contactpointnano.ch‘s second webinar and learn about how to navigate new regulations for medical devices and new requirements regarding nanomaterials. Time: 13.00
Save the date: NME21
Due to the sanitary situation, Nanomed Europe 21 (NME21) is postponed to Tuesday, September 7 – Thursday, September 9, 2021, still in St. Gallen, Switzerland: www.nme21.eu Do not miss this
Microplastics and Nanopla...
Recently, the European Commission published a study that provides further information on the intentional uses of microplastic particles in products and the risks they pose to human
Nanomedicine: The Minuten...
Tiny particles that can fight cancer or that can easily pass through any interface within our body are a great promise for medicine. But there is little
Crucial results for coron...
Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are
Characterizing Nanopartic...
Live Webinar, Thursday 19 November, 15:00 (Zürich). Guest speaker Dr. Sandor Balog, Details, Please register for this event using this link
Publications on Synthetic...
Action plan Synthetic Nanomaterials Report by the Federal Council of 9 April 2008 Synthetic Nanomaterials Risk Assessment and Risk ManagementBasic report for the Swiss Action Plan, 2007